CLL Testing & Imaging

December 4, 2024

BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient Outcomes in CLL

BeiGene and CLL Society partnered on Test Before Treat, educating healthcare providers and CLL / SLL patients about the importance of biomarker testing.

May 2, 2023

Dr. John Seymour on IgHV Mutational Status

Dr. Koffman and Dr. Seymour discuss our latest learnings on how IGHV mutational status affects treatment outcomes.

January 5, 2022

Real-World Testing Patterns for Risk Assessment and Implications on the Adoption of Novel Therapeutics in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL / SLL): IgHV Mutation Status, FISH Cytogenetic, and Immunophenotyping

As new and better treatments are developed to treat Chronic Lymphocytic Leukemia, and Small Lymphocytic Lymphoma (CLL / SLL), testing for subtypes of the disease is becoming more important for prognosis and selection of the best treatment options.

October 18, 2021

CLL Society Ed Forum On Demand: The Right Tests at the Right Time – Session 5

CLL Society Ed Forum On Demand: The Right Tests at the Right Time CLL Society Resources and Test Before Treat™

August 27, 2021

Patient, Know Thyself

Patient, Know Thyself Mark Hoffman is a long-time CLL patient advocate and facilitator of the CLL Society Patient & Caregiver Support Group in San Diego, CA. In this article from Cancer Health, Mark echoes the importance of the Test Before Treat™ campaign by sharing his story. When Mark was

March 17, 2021

ASH 2020: Dr. Anthony Mato Discusses the Impact of del(17p) on Survival of Patients with Chronic Lymphocytic Leukemia (CLL) Treated with First-Line Ibrutinib

ASH 2019: Dr. David Maloney on CAR-T therapy in CLL (chronic lymphocytic leukemia)

March 11, 2021

ASH 2020: Dr. Adrian Wiestner Discusses the Importance of Test Before Treat™ Predictive and Prognostic Biomarker Testing in Patients with Chronic Lymphocytic Leukemia (CLL)

At the American Society of Hematology’s (ASH) 2020 conference, there was research on looking at the genome of CLL and how different genetic markers might have predictive and value. Dr. Brian Koffman, Chief Medical Officer and Executive Vice President of CLL Society, interviewed Dr. Adrian Wiestner, a senior investigator at

February 6, 2021

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat

CLL Society On Demand Ed Forum: ASH 2020 Comes to You – Session 1: Encouraging Updates on Drugs in Development + the Sad State of Test Before Treat Recorded Thursday, February 4, 2021 https://youtu.be/U9f7OCdcJcs Continue to Session 2: CLL Treatments: Chemotherapy, Immunotherapy, and Targeted Agents CLL Society Resources Download

January 29, 2021

iwCLL 2019: Dr. Nicole Lamanna on Biomarker Testing for Chronic Lymphocytic Leukemia (CLL)

As the science of chronic lymphocytic leukemia has advanced, we have learned much more detailed information about its biology and the specific chromosomes, genes, and proteins that contribute to the disease. Checking for specific abnormalities in chromosomes and genetic variants can help doctors evaluate a patient’s prognosis and predict

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.